Blog | PPD Inc

Prepare Now for EU Clinical Trial Regulation Go-Live Date

PPD’s cross-functional EU CTR readiness team is keeping a close eye on the new EU CTR and its potential impacts, working to embrace this change.

The Biggest Problems We Face Fighting Infectious Diseases

Establishing a Microbiology Program and Custom Preclarus® Bacteriology Module within PPD Laboratories’ Central Lab to Meet the Needs of Unique Customer Programs

Microbiology section supervisor, Ronnie Heflin, provides thoughtful discussion on the challenges and considerations that surround microbiology service offerings within a central lab.

Devices/Diagnostics: Emergency Use Authorizations during the COVID-19 Pandemic

Learn more about the increased uptake of Emergency Use Authorizations (EUA) for medical devices during the COVID-19 pandemic

REMS: To Outsource or Not to Outsource?

Knowing when to outsource a REMS program versus developing one internally.

PPD’s Early Development Services Can Help Expedite the Clinical Process

Leveraging Decentralized Real-World Evidence (RWE) Data Collection Strategies During the COVID-19 Pandemic and Beyond

Doctor virtually collecting real-world evidence from a patient.

New and Emerging Regulatory Guidance for Cell and Gene Therapy Product Development

Considerations for cell and gene therapy development have shifted based on recent updates published by the EMA and FDA.

The Critical Need for Pregnancy Registry Studies and Robust Safety Monitoring in COVID-19 Vaccines

Cropped shot of young beautiful woman on third trimester of pregnancy. Close up of pregnant female with arms on her round belly.